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Introduction 26
Identifying the causative agent implicated in an outbreak is crucial for selecting the 27 suitable treatment and/or control measures (1). For example, around 25 pathogens 28 can cause influenza like symptoms in the acute phase and up to 20 pathogens have 29 to be considered for diarrhoea. 30
For direct detection of pathogens, polymerase chain reaction (PCR) is a widely used 31 and well-established test for molecular diagnostics. Since specificity of PCR 32 oligonucleotides depends on known sequences of specific target genes, false 33 negative PCR result might be obtained due to a mismatching sequence of a novel 34 variant of a known pathogen or because of a new emerging infectious agent. An 35 alternative promising technology is next generation Sequencing (NGS), which can be 36 applied to identify the pathogen responsible for the outbreak through sequencing of 37 all nucleic acids in a sample allowing generic detection not limited by specific 38 oligonucleotide design. Additionally, NGS data sets on detected infectious agents 39 can be use for phylogenetic and molecular epidemiological analysis to provide 40 insights on strain and origin of the agent. This information can be crucial for 41 organization and distribution of resources during the outbreak control (2, 3). 42
There are many NGS technologies available such as sequencing by synthesis, using 43
HiSeq and MySeq devices (Illumina, USA). These devices have a high data output, 44 an error rate below 2% and the possibility to sequence several samples in parallel 45 (4). Nevertheless, there is a high logistic demand through weight, size and costs of 46 the equipment. Furthermore, cumbersome and long sample and library preparation 47 protocols are necessary in order to generate results (4, 5). In contrast, nanopore 48 sequencing technology (Oxford Nanopore Technology, UK) uses a pore-protein 49 embedded in a membrane to identify individual nucleotide by the unique change in 50 electrical conductivity as a DNA molecule passes through the nanopore protein. 51
Recently, Oxford Nanopore Technology developed a pocket sized (10.5 + 3.5 + 2.5 52 cm) sequencing device (MinION) which has the potential to be applied in the field or 53 rural areas. A flow cell containing the required nanopores is inserted into the MinION 54 in order to operate the sequencing run. The MinION device operates at a constant 55 sequencing temperature (34°C) and translates the measured changes in current to a 56 real-time nucleotide sequence via USB connection to a laptop (5) (6) (7) (8) . 57
Here we describe the establishment of a protocol for rapid identification of RNA 58 viruses combining. random isothermal amplification and nanopore sequencing using 59
Zika virus (ZIKV) as model virus. The protocol was performed in a mobile suitcase 60 laboratory (figure 1) in order to allow implementation in outbreak situation (9). 61 62
Materials and Methods 63
Sample origin 64 ZIKV strains were provided by WHO collaborating Center at the Institute Pasteur of 65 Dakar in Senegal. The monkey strain MR766 and the human strain HD78788 were 66 isolated in 1947 (in Uganda) and 1991 (in Senegal) in Africa, respectively, during 67 surveillance. Viral stocks were prepared by inoculating viral strains into Aedes 68 pseudoscutellaris clone 61 (AP61) monolayer. Cells were grown in cell culture flasks 69 (25 cm2) until they reached a confluence of approximately 80%. The medium was 70 discarded, and 150 µl virus solution was added to the cells. The flasks were gently 71 agitated every 15 min during incubation to enhance viral infection. After 1 h, 5 ml of 72
Leibovitz 15 (L-15) growth medium (GibcoBRL, Grand Island, NY, USA) 73 supplemented with 5% heat-inactivated fetal bovine serum (FBS) (GibcoBRL, Grand Island, NY, USA), 10% Tryptose Phosphate 1% glutamine, 1% penicillin-75 streptomycin, 0.05% amphotericin B [Fungizone] (Sigma, Gmbh, Germany) was 76 added and the infected cells were incubated at 28°C without CO2 until a cytopathic 77 effect was observable.. Viral infection was confirmed by an indirect 78 immunofluorescence assay (IFA) using specific hyper-immune mouse ascitic fluid, as 79 described previously (Digoutte et al., 1992) . 80
Sample preparation 81
Zika virus (ZIKV) RNA was extracted from cell culture supernatant using the QIAamp 82 Viral RNA Mini Kit (QIAGEN Hilden, Germany) following the manufacturer`s 83 instructions. The RNA quantity was measured by NanoDrop ND-1000 spectrometer 84 (Thermo Scientific, Waltham, MA, USA). For elimination of genomic DNA and reverse 85 transcription, the QuantiTect Reverse Transcription Kit (QIAGEN Hilden, Germany) 86 was employed using a prolonged incubation time (25 min) for the reverse 87 transcription step. Second strand cDNA Synthesis was performed with the NEBNext 88 mRNA Second Strand Synthesis Module (New England Biolabs, Ipswich, MA, USA). 89
The double-stranded cDNA (ds-cDNA) was purified with the 1.8X Agencourt AMPure 90 XP Beads Kit (Beckman Coulter, Brea, CA, USA), eluted in 55 µl nuclease-free water 91 and quantified (NanoDrop ND-1000). To fragment and increase the amount of DNA, 92 random amplification was done using the REPLI-g UltraFast Mini Kit (QIAGEN 93 Hilden, Germany), Briefly, 1 µl of ds-cDNA, containing at least 10 ng, was incubated 94 with 1 µl denaturation buffer at room temperature. To terminate the denaturation, 2 µl 95 neutralization buffer was added after 3 min. The denatured ds-cDNA was mixed with 96 16 µl of the master mix containing 15 µl REPLI-g UltraFast reaction buffer and 1 µl 97 REPLI-g UltraFast DNA polymerase and incubated at 30°C for 90 min. The reaction 98 mix was heated to 65°C for 3 min to inactivate the reaction enzymes. Then, the DNA 99 was purified with the 1.8X Agencourt AMPure XP Beads Kit, eluted in 30 µl nuclease 100 free water and quantified (NanoDrop ND-1000). 101
Library preparation and sequencing 102
For library preparation, the protocol for amplicon sequencing, SQK-NSK007, was 103 used as recommended by Oxford Nanopore Technology. Briefly, 45 µl containing at 104 least 1µg ds-cDNA were used for end-repairing and dA-tailing using the NEBNext 105
Ultra II end-repair / dA-tailing module. The end-prepped DNA was purified with the 106 1.8X Agencourt AMPure XP Beads Kit and eluted in 31 µl nuclease free water. DNA 107 recovery aim was at least 700 ng/µl. Adapter ligation and tethering was carried out 108 with the NEB Blunt/TA Ligase Master Mix. The DNA was purified using the 109 Dynabeads® MyOne™ Streptavidin C1 Kit (Thermo Fisher Scientific, Waltham, MA, 110 USA) and solved in 25 µl of Oxford Nanopores` Elution Buffer. Six microliter of the 111 adapted and tethered DNA was mixed with 31.5 µl nuclease free water and 37.5 µl of 112
Oxford Nanopores` Running Buffer FM1 and then loaded into the flow cells in the 113 MinION device. 114
Data processing 115
The MinION device generates data in fast5 format. These reads were processed with 116 the METRICHORE AGENT (Oxford Nanopore Technology, Oxford, UK). Afterwards, 117 the files were transformed to fastq format with PORETOOLS (10). Duplicate reads 118 were deleted and the remaining sequences were loaded in BLAST search using 119 GENEIOUS 9.1.6 (Biomatters Ltd., Auckland, New Zealand). Contigs were aligned to 120 Zika strain KF383115 via Map to Reference option in GENEIOUS. Moreover, it has a higher data output (15 Giga bases) in comparison to the MinION 145 (10 Giga bases). Nevertheless, read length by MiSeq is limited to around 300 bp and 146 a maximum of 22-25 million reads can be produced in a run time between 4h and 147 56h (11, 12) . In contrast, the MinION has through its nanopore technology no limit in 148 read length and number. Moreover, reads are generated in 20-120 min and data are 149 easily accessible on laptop or PC. 150
We have discovered that 1/5 of the correct ZIKV reads was placed into the "fail" file. 151
The METRICHORE AGENT classifies the reads into pass and fail reads by neuronal 152 network computing assessing definite conductivity readout events at the pore exit for 153 5-6 mers. This complicated sequence definition needs quality scoring to decide on 154 the statistical trustworthiness of the sequencing result. Fails are defined through the 155 following approach. Initially base calling (1D base calling) of template and 156 complement reads is performed separately. If the resulting sequence length ratio is 157 between 0.5-2.0, all sequences are stacked together for base 2D base calling. If 158 resultant 2D sequences are assessed with a Q-score > 9 they are sorted into a 159 FAST5 fail sequence file (13). 160
Short Illumina device reads have a 0.1% non-random error rate, which means an 161 error at one site can still dominate the base calling process. The MinION reads have 162 a 10% error rate but sites are distributed at random throughout the sequence which 163 is compensated for by base calling and which therefore do not dominate at one site 164 reducing the overall error rate in comparison to Illumina reads (14). Our results 165 suggest that the analysis algorithm and the Q-score need to be optimised for viral 166 RNA sequences. At this current development stage therefore a recommended 167 assembly approach would be first to use all pass reads to identify the infectious 168 agent. To improve the result, the fail reads can be included in a 2 nd step. 169
In general however the passed sequence assembly result already produce a robust 170 result with a average coverage of 40. 171
The MinION was successfully used in the Ebola virus outbreak in Guinea (7) and 172 during the Zika virus outbreak in Brazil (15). In both cases, specific PCR fragment 173 sequencing strategies were used. RT-PCR assays were applied to reverse transcribe 174 RNA and create multiple fragments to increase the sequencing efficacy (7, 16) . This 175 strategy limits sequencing output to targeted agents, which is ideal for molecular 176 epidemiological analysis. The use of PCR leads to logistic issues due to heavy 177 devices and requirement of a cold chain for the reagents. In Brazil, this was solved 178 by transporting the whole laboratory in a caravan. The generic sequencing approach 179 described here is intended for diagnostic identification of unknown infectious agents. 180 It uses only random isothermal steps throughout the procedure and PCR cycling is 181 not required which avoids the use of a thermal cycler. 182
We have already shown that isothermal amplification can be easily implemented in a 183 mobile suitcase laboratory (9, 17, 18) and we successfully adapted this concept for 184 the workflow needed for library preparation for the MinION sequencing procedure 185 (figure 1). The suitcase, contains all materials and reagents needed for sequencing in 186 one box of 56.0 + 45.5 + 26.5 cm in size and less than 23 kg in weight. 187
All steps of data collection and analysis except the BLAST search were performed 188 offline using MINKNOW and METRICHORE AGENT as well as GENEIOUS. This is a 189 major improvement since during the Ebola outbreak base calling for MinION datasets 190 was only possible through cloud computing which needed internet capacity often not 191 available locally (7). The simple structure and clear layout of these analysis 192 programmes makes it easy for users without bioinformatic background to obtain 193 basic information about origin and phylogeny of the sequenced target. Therefore, a 194 bioinformatician is not necessarily needed for analysis of the datasets obtained. To 195 perform BLAST offline a database of infectious agent sequences only located on the 196 laptop needs to be assembled. It could be replenished with new entries to GenBank 197 whenever online. 198 Currently, the following challenges have to be solved. In our hands, the sequencing 199 reagents can be kept at 25°C for one day without any changes in their efficacy 200 (confirmed by Oxford Nanopore Technologies, UK). However for long-term storage a 201 -20°C freezer is still required. Moreover, the price per sequencing run is very high 202 (around $1500), as one flow cell costs between $500 and $900 depending on the 203 amount of ordered flow cells. In addition, the shelf life of the flow cells is around 8 204 weeks at 4°C. One of the biggest drawbacks is that the manufacturer is progressively 205 changing the reagents and flow cells so that it is difficult to match biochemistry to 206 flow cells. 207
The goal of this pilot study was to establish a protocol for pathogen identification 208 during an outbreak field investigation. In principle this seems possible in a suitcase 209 laboratory setup. The next steps will be to assemble an offline solution to compare 210 identified sequences with preloaded database and to identify cold chain independent 211 reagents. 212 213 214 215
